Rhein: A Review of Pharmacological Activities

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Zhou, Yan Xi ^a,b   Xia, Wei ^a   Yue, Wei ^a   Peng, Cheng ^b   Rahman, Khalid ^c   Zhang, Hong ^a,d  

^a SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BACTERIAL DNA; CHONDROPROTECTIVE AGENT; INTERLEUKIN 1; LAXATIVE; LIVER PROTECTIVE AGENT; PROTECTIVE AGENT; RENAL PROTECTIVE AGENT; RHEIN; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CHONDROPROTECTION; DRUG ACTIVITY; HUMAN; LIPID LOWERING ACTIVITY; LIVER PROTECTION; NEPHROPROTECTIVE ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PURGATIVE ACTIVITY; RENAL PROTECTION; REVIEW;

EID: 84936817432     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/578107     Document Type: Review

References (79)

1. B. Layek, T. S. Kumar, R. K. Trivedi, R. Mullangi, and N. R. Srinivas, "Development and validation of a sensitive LCMS/ MS method with electrospray ionization for quantitation of rhein in human plasma: Application to a pharmacokinetic study," Biomedical Chromatography, vol. 22, no. 6, pp. 616-624, 2008.
2. M.-Z. Guo, X.-S. Li, D.-M. Shen, X.-Q. Guan, H.-R. Xu, and J. Gao, "Effect of Rhein on the development of hepatic fibrosis in rats," Zhonghua Gan Zang Bing Za Zhi, vol. 11, no. 1, pp. 26-29, 2003.
3. F. Moldovan, J. P. Pelletier, F.-C. Jolicoeur, J.-M. Cloutier, and J. Martel-Pelletier, "Diacerhein and rhein reduce the ICE-induced IL-1 and IL-18 activation in human osteoarthritic cartilage," Osteoarthritis and Cartilage, vol. 8, no. 3, pp. 186-196, 2000.
4. H. Du, J.-Q. Shao, P. Gu, J. Wang, and Z.-H. Liu, "Effect of early intervention with rhein on islet function in db/db mice," Nan Fang Yi Ke Da Xue Xue Bao, vol. 31, no. 9, pp. 1526-1529, 2011.
5. S.-K. Heo, H.-J. Yun,W.-H. Park, and S.-D. Park, "Rhein inhibits TNF-induced human aortic smooth muscle cell proliferation via mitochondrial-dependent apoptosis," Journal of Vascular Research, vol. 46, no. 4, pp. 375-386, 2009.
6. M. L. Lin, J. G. Chung, Y. C. Lu, C. Y. Yang, and S. S. Chen, "Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor," Oral Oncology, vol. 45, no. 6, pp. 531-537, 2009.
7. Y.-Y. Chen, S.-Y. Chiang, J.-G. Lin et al., "Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9," International Journal of Oncology, vol. 36, no. 5, pp. 1113-1120, 2010.
8. P. Shi, Z. Huang, and G. Chen, "Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells," The American Journal of Chinese Medicine, vol. 36, no. 4, pp. 805-813, 2008.
9. T. C. Hsia, J. S. Yang,G. W. Chenet al., "The roles of endoplasmic reticulum stress and Ca2+ on rhein-induced apoptosis in A-549 human lung cancer cells," Anticancer Research, vol. 29, no. 1, pp. 309-318, 2009.
10. J.-C. Tang, H. Yang, X.-Y. Song et al., "Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes," Phytotherapy Research, vol. 23, no. 2, pp. 159-164, 2009.
11. D.-X. Bian, J. Liu, L. Lu et al., "Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet," Zhonghua Shi YanHe Lin Chuang Bing Du Xue Za Zhi, vol. 27, no. 5, pp. 328-331, 2013.
12. X. Sheng, M. Wang, M. Lu, B. Xi, H. Sheng, and Y. Q. Zang, "Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice," The American Journal of Physiology-Endocrinology and Metabolism, vol. 300, no. 5, pp. E886-E893, 2011.
13. T. A. Wynn, "Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases," The Journal of Clinical Investigation, vol. 117, no. 3, pp. 524-529, 2007.
14. M.-Z. Guo, X.-S. Li, H.-R. Xu, Z.-C. Mei,W. Shen, and X.-F. Ye, "Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats," Acta Pharmacologica Sinica, vol. 23, no. 8, pp. 739-744, 2002.
15. D. He, L. Lee, J. Yang, and X. Wang, "Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy," Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1219-1226, 2011.
16. S.-N. Peng, H.-H. Zeng, A.-X. Fu, X.-W. Chen, and Q.-X. Zhu, "Effects of rhein on intestinal epithelial tight junction in IgA nephropathy,"World Journal of Gastroenterology, vol. 19, no. 26, pp. 4137-4145, 2013.
17. S.-N. Peng, H.-H. Zeng, A.-X. Fu, X.-W. Chen, and Q.-X. Zhu, "Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats," Indian Journal of Pharmacology, vol. 45, no. 2, pp. 174-179, 2013.
18. J. Su, L. P. Yin, X. Zhang, B. B. Li, L. Liu, and H. Li, "Chronic allograft nephropathy in rats is improved by the intervention of rhein," Transplantation Proceedings, vol. 45, no. 6, pp. 2546-2552, 2013.
19. Z. Q. Ji, C. W. Huang, C. J. Liang, W. W. Sun, B. Chen, and P. R. Tang, "Effects of rhein on activity of caspase-3 in kidney and cell apoptosis on the progression of renal injury in glomerulosclerosis," Zhonghua Yi Xue Za Zhi, vol. 85,no. 26,pp. 1836-1841, 2005.
20. D.-Q. Yu, Y. Gao, and X.-H. Liu, "Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats," Zhong Yao Cai, vol. 33, no. 4, pp. 570-574, 2010.
21. C. Sanchez, M. Mathy-Hartert, M. A. Deberg, H. Ficheux, J.-Y. L. Reginster, and Y. E. Henrotin, "Effects of rhein on human articular chondrocytes in alginate beads," Biochemical Pharmacology, vol. 65, no. 3, pp. 377-388, 2003.
22. D. Borderie, A. Hernvann, H. Lemarechal, C.-J. Menkes, and O. Ekindjian, "Inhibition of the nitrosothiol production of cultured osteoarthritic chondrocytes by rhein, cortisol and diclofenac," Osteoarthritis and Cartilage, vol. 9, no. 1, pp. 1-6, 2001.
23. J.-P. Pelletier, F. Mineau, J. C. Fernandes, N. Duval, and J. Martel-Pelletier, "Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes," Journal of Rheumatology, vol. 25, no. 12, pp. 2417-2424, 1998.
24. J. Deffaud, M. Kirchmeyer, F. Domagala et al., "Modulatory effect of rhein on IL-1-induced responses in human chondrocytes: A comparative study between antibody microarrays and specific ELISAs," Biorheology, vol. 45, no. 3-4, pp. 439-455, 2008.
25. J.-P. Pelletier, D. Lajeunesse, P. Reboul et al., "Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone," Journal of Rheumatology, vol. 28, no. 4, pp. 814-824, 2001.
26. M. Yaron, I. Shirazi, and I. Yaron, "Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures," Osteoarthritis and Cartilage, vol. 7, no. 3, pp. 272-280, 1999.
27. J. Martel-Pelletier, F. Mineau, F.-C. Jolicoeur, J.-M. Cloutier, and J.-P. Pelletier, "In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor- systems in human osteoarthritic synovium and chondrocytes," The Journal of Rheumatology, vol. 25, no. 4, pp. 753-762, 1998.
28. C. Gigant-Huselstein, D. Dumas, E. Payan et al., "In vitro study of intracellular IL-1 production and 1 integrins expression in stimulated chondrocytes-effect of rhein," Biorheology, vol. 39, no. 1-2, pp. 277-285, 2002.
29. F. Legendre, A. Heuze, K. Boukerrouche et al., "Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis," Scandinavian Journal of Rheumatology, vol. 38,no. 2, pp. 104-111, 2009.
30. G. Martin, P. Bogdanowicz, F. Domagala, H. Ficheux, and J.-P. Pujol, "Rhein inhibits interleukin-1-induced activation of MEK/ERK pathway and DNA binding of NF-B and AP-1 in chondrocytes cultured in hypoxia: A potential mechanism for its disease-modifying effect in osteoarthritis," Inflammation, vol. 27, no. 4, pp. 233-246, 2003.
31. F. Legendre, P. Bogdanowicz, G. Martin et al., "Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways," Clinical and Experimental Rheumatology, vol. 25, no. 4, pp. 546-555, 2007.
32. A. F. Mendes, M. M. Caramona, A. P. de Carvalho, and M. C. Lopes, "Diacerhein and rhein prevent interleukin-1betainduced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha," Pharmacology and Toxicology, vol. 91, no. 1, pp. 22-28, 2002.
33. T. Tamura, N. Kosaka, J. Ishiwa, T. Sato, H. Nagase, and A. Ito, "Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1,-3,-9 and-13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes," Osteoarthritis and Cartilage, vol. 9, no. 3, pp. 257-263, 2001.
34. T. Tamura and K. Ohmori, "Rhein, an active metabolite of diacerein, suppresses the interleukin-1-induced proteoglycan degradation in cultured rabbit articular chondrocytes," Japanese Journal of Pharmacology, vol. 85, no. 1, pp. 101-104, 2001.
35. L. Savarino, A. Fioravanti, G. Leo, R. Aloisi, and M. Mian, "Anthraquinone-2,6-disulfonic acid as a disease-modifying osteoarthritis drug: An in vitro and in vivo study," Clinical Orthopaedics and Related Research, no. 461, pp. 231-237, 2007.
36. G. Hu, J. Liu, Y.-Z. Zhen et al., "Rhein inhibits the expression of vascular cell adhesion molecule 1 in human umbilical vein endothelial cells with or without lipopolysaccharide stimulation," The American Journal of Chinese Medicine, vol. 41, no. 3, pp. 473-485, 2013.
37. X.-D. Cong, M.-J. Ding, D.-Z. Dai, Y. Wu, Y. Zhang, and Y. Dai, "ER stress, P66shc, and P-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats," Inflammation, vol. 35, no. 3, pp. 1031-1040, 2012.
38. T. Tamura, T. Yokoyama, and K. Ohmori, "Effects of diacerein on indomethacin-induced gastric ulceration," Pharmacology, vol. 63, no. 4, pp. 228-233, 2001.
39. X.-F. Zhong, G.-D. Huang, T. Luo, Z.-Y. Deng, and J.-N. Hu, "Protective effect of rhein against oxidative stress-related endothelial cell injury," Molecular Medicine Reports, vol. 5, no. 5, pp. 1261-1266, 2012.
40. Y.-L. Zhao, G.-D. Zhou, H.-B. Yang et al., "Rhein protects against acetaminophen-induced hepatic and renal toxicity," Food and Chemical Toxicology, vol. 49,no. 8, pp. 1705-1710, 2011.
41. M. A. Glinn, C. P. Lee, and L. Ernster, "Pro-and antioxidant activities of the mitochondrial respiratory chain: factors influencing NAD(P)H-induced lipid peroxidation," Biochimica et Biophysica Acta-Bioenergetics, vol. 1318,no. 1-2, pp. 246-254, 1997.
42. S. Lin, J.-J. Li, M. Fujii, and D.-X. Hou, "Rhein inhibits TPAinduced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway," International Journal of Oncology, vol. 22, no. 4, pp. 829-833, 2003.
43. G. Aviello, I. Rowland, C. I. Gill et al., "Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells," Journal of Cellular and Molecular Medicine, vol. 14, no. 7, pp. 2006-2014, 2010.
44. V. E. Fernand, J. N. Losso, R. E. Truax et al., "Rhein inhibits angiogenesis and the viability of hormone-dependent and-independent cancer cells under normoxic or hypoxic conditions in vitro," Chemico-Biological Interactions, vol. 192, no. 3,pp. 220-232, 2011.
45. Y. Y. Chen, S. Y. Chiang, J. G. Lin et al., "Emodin, aloe-emodin and rheininducedDNAdamage and inhibitedDNArepair gene expression in SCC-4 human tongue cancer cells," Anticancer Research, vol. 30, no. 3, pp. 945-952, 2010.
46. S.-W. Ip, Y.-S. Weng, S.-Y. Lin, N.-Y. Tang, C.-C. Su, and J.-G. Chung, "The role of Ca+2 on rhein-induced apoptosis in human cervical cancer Ca Ski cells," Anticancer Research, vol. 27, no. 1A, pp. 379-390, 2007.
47. S. Lin, M. Fujii, and D.-X. Hou, "Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independentmitochondrial death pathway,"Archives of Biochemistry and Biophysics, vol. 418, no. 2, pp. 99-107, 2003.
48. M.-L. Lin, S.-S. Chen, Y.-C. Lu et al., "Rhein induces apoptosis through induction of endoplasmic reticulum stress and Ca2+-dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells," Anticancer Research, vol. 27, no. 5, pp. 3313-3322, 2007.
49. F. Raimondi, P. Santoro, L. Maiuri et al., "Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro," Journal of Pediatric Gastroenterology and Nutrition, vol. 34, no. 5, pp. 529-534, 2002.
50. W. W. Lai, J. S. Yang, K. C. Lai et al., "Rhein induced apoptosis through the endoplasmic reticulum stress, caspase-and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells," In Vivo, vol. 23,no. 2, pp. 309-316, 2009.
51. P. L. Kuo, Y. L. Hsu, L. T. Ng, and C. C. Lin, "Rhein inhibits the growth and induces the apoptosis of Hep G2," Planta Medica, vol. 70, no. 1, pp. 12-16, 2004.
52. Y.-H. Huang and Y.-S. Zhen, "Rhein induces apoptosis in cancer cells and shows synergy with mitomycin," Yao Xue Xue Bao, vol. 36, no. 5, pp. 334-338, 2001.
53. H. Du, J. Shao, P. Gu, B. Lu, X. Ye, and Z. Liu, "Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice," Journal of Endocrinological Investigation, vol. 35, no. 6, pp. 607-612, 2012.
54. H. Du, J. Shao, P. Gu, B. Lu, J. Wang, and Z. Liu, "Effect of rhein treatment on first-phase insulin secretory function in db/db mice," Zhongguo Zhongyao Zazhi, vol. 35, no. 20, pp. 2764-2767, 2010.
55. J. Liu, Z. Chen, Y. Zhang et al., "Rhein protects pancreatic -cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia," Diabetes, vol. 62, no. 11, pp. 3927-3935, 2013.
56. J. Zhu, Z. Liu, and Y. Li, "Inhibition of glucose transporter 1 overexpression in mesangial cells by rhein," Zhonghua Nei Ke Za Zhi, vol. 40, no. 8, pp. 537-542, 2001.
57. Z. H. Tan,Y. J. Shen, J. N. Zhao,H. Y. Li, and J. Zhang, "Effects of rhein on the function of human mesangial cells in high glucose environment," Yaoxue XueBao, vol. 39, no. 11, Article ID 0513-4870(2004)11-0881-06, pp. 881-886, 2004.
58. Z. Liu, Y. Li, and J. Zhang, "Modulatory effect of transforming growth factor-beta and Rhein on glucose transporter-1 in human glomerular mesangial cells," Zhonghua Yi Xue Za Zhi, vol. 79, no. 10, pp. 780-783, 1999.
59. J. Zhang, Z. Liu, Z. Chen, Y. Li, and L. Li, "Effect of rhein on glucose transporter-1 expression and its function in glomerular mesangial cells," Chinese Medical Journal, vol. 112, no. 12, pp. 1077-1079, 1999.
60. S. Castiglione, M. Fanciulli, T. Bruno et al., "Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions," Anti-Cancer Drugs, vol. 4, no. 3, pp. 407-414, 1993.
61. S. B. Choi, B. S. Ko, S. K. Park, and J. S. Jang, "Insulin sensitizing and -glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma," Life Sciences, vol. 78, no. 9, pp. 934-942, 2006.
62. Z.-H. Liu, Y.-J. Li, Z.-H. Chen, D. Liu, and L.-S. Li, "Glucose transporter in human glomerularmesangial cellsmodulated by transforming growth factor-beta and rhein," Acta Pharmacologica Sinica, vol. 22, no. 2, pp. 169-175, 2001.
63. J. G. Chung, M. F. Tsou, H. H. Wang et al., "Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients," Journal of Applied Toxicology, vol. 18, no. 2, pp. 117-123, 1998.
64. L. Yu, H. Xiang, J. Fan et al., "Global transcriptional response of Staphylococcus aureus to Rhein, a Natural Plant Product," Journal of Biotechnology, vol. 135, no. 3, pp. 304-308, 2008.
65. E. Leng-Peschlow, "Sennoside-induced secretion is not caused by changes in mucosal permeability or Na+, K+-ATPase activity," Journal of Pharmacy and Pharmacology, vol. 45, no. 11, pp. 951-954, 1993.
66. T. Frieling, C. Rupprecht, and M. Schemann, "Rhein stimulates electrogenic chloride secretion by activation of submucosal neurons in guinea pig colon," Pharmacology, vol. 47, no. 1, pp. 70-76, 1993.
67. X. Sheng, X. Zhu, Y. Zhang et al., "Rhein protects against obesity and related metabolic disorders through liver X receptormediated uncoupling protein 1 upregulation in brown adipose tissue," International Journal of Biological Sciences, vol. 8, no. 10, pp. 1375-1384, 2012.
68. Q. Liu, X.-L. Zhang, R.-Y. Tao et al., "Rhein, an inhibitor of adipocyte differentiation and adipogenesis," Journal of Asian Natural Products Research, vol. 13, no. 8, pp. 714-723, 2011.
69. Z.-H. He, R. Zhou, M.-F. He et al., "Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei," Phytomedicine, vol. 18, no. 6, pp. 470-478, 2011.
70. Q. Wang, N.-N. Zhang, H.-Y. Li, M. Jiang, J. Gao, and G. Bai, "Active ingredients in rhubarb with anti-proliferative effects on scar fibroblasts," Yaoxue Xuebao, vol. 47, no. 12, pp. 1618-1622, 2012.
71. F. A. Badria and A. S. Ibrahim, "Evaluation of natural anthracene-derived compounds as antimitotic agents," Drug Discoveries & Therapeutics, vol. 7, no. 2, pp. 84-89, 2013.
72. Q. Gao, W.-S. Qin, Z.-H. Jia et al., "Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy," Planta Medica, vol. 76, no. 1, pp. 27-33, 2010.
73. L. Peng, J. Yang, C. Ning et al., "Rhein inhibits integrin-linked kinase expression and regulates matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in high glucoseinduced epithelial-mesenchymal transition of renal tubular cell," Biological and Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1676-1685, 2012.
74. X. Liu, J. Cheng, X. Zheng et al., "Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology," International Immunopharmacology, vol. 9, no. 9, pp. 1021-1031, 2009.
75. S. C. Kang, C. M. Lee, E. S. Choung et al., "Anti-proliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum," Archives of Pharmacal Research, vol. 31, no. 6, pp. 722-726, 2008.
76. S.-K. Heo, H.-J. Yun, E.-K. Noh, and S.-D. Park, "Emodin and rhein inhibit LIGHT-inducedmonocytesmigration by blocking of ROS production," Vascular Pharmacology, vol. 53, no. 1-2, pp. 28-37, 2010.
77. B. Singh, J. R. Nadkarni, R. A. Vishwakarma, S. B. Bharate, M. Nivsarkar, and S. Anandjiwala, "The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound rhein exhibits antiallergic activity via mast cell stabilization and lipoxygenase inhibition," Journal of Ethnopharmacology, vol. 141, no. 1, pp. 469-473, 2012.
78. J. Zhu, Z. Liu, H. Huang, Z. Chen, and L. Li, "Rhein inhibits transforming growth factor 1 induced plasminogen activator inhibitor-1 in endothelial cells," Chinese Medical Journal, vol. 116, no. 3, pp. 354-359, 2003.
79. H. Li, C. Liang, Q. Chen, and Z. Yang, "Rhein: A potential biological therapeutic drug for intervertebral disc degeneration," Medical Hypotheses, vol. 77, no. 6, pp. 1105-1107, 2011.